Tirzepatide 30mg

Dual GIP/GLP-1 agonist that supports significant weight loss by reducing appetite and improving insulin sensitivity.

Tirzepatide activates both GIP and GLP-1 receptors simultaneously, making it one of the most potent metabolic research compounds available. Research demonstrates superior appetite suppression and blood sugar regulation compared to single-agonist compounds.

Purity: ≥98% | Form: Lyophilized Powder | Storage: 2–8°C

⚠️ FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION. Handle by qualified research professionals only.